In addition to the upcoming SPaL Phase 3 trial, TB Alliance plans to explore delivering a sorfequiline-based regimen as a long-acting injectable (LAI), a formulation that could potentially help reduce ...
AMR not only threatens public health but also makes common infections more difficult and costly to treat. The World Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback